Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Spinal Muscular Atrophy (SMA)
Trial Locations (15)

10032

Columbia University Medical Center, New York

13210

State University of New York Upstate Medical Center, Syracuse

20010

Children's National Medical Center, Washington D.C.

37212

Vanderbilt University, Nashville

43205

Nationwide Children's Hospital, Columbus

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

63110

Washington University in St. Louis School of Medicine, St Louis

64108

Children's Mercy Hospital, Kansas City

75235

Children's Medical Center of Dallas, Dallas

80045

Children's Hospital Colorado, Aurora

84132

University of Utah Health Sciences Center, Salt Lake City

90095

University of California - Los Angeles, Los Angeles

95616

University of California - Davis, Davis

97239

Doernbecher Children's Hospital, Portland

02115

Boston Children's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Cure SMA

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

University of Iowa

OTHER

lead

Ohio State University

OTHER

NCT01736553 - Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development | Biotech Hunter | Biotech Hunter